Global Newborn and Prenatal Genetic Testing Supply, Demand and Key Producers, 2026-2032

April 2026 | 141 pages | ID: GEEC7806A73DEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Newborn and Prenatal Genetic Testing market size is expected to reach $ 6665 million by 2032, rising at a market growth of 9.0% CAGR during the forecast period (2026-2032).

Newborn and Prenatal Genetic Testing refers to the set of genetic tests performed before birth and shortly after birth to assess the risk or presence of inherited and congenital conditions. It includes prenatal tests that evaluate fetal genetic risk during pregnancy and newborn tests that screen infants for serious conditions that may not be clinically apparent at delivery, with results used to guide confirmatory diagnostics, treatment decisions, and long term follow up care.

The newborn and prenatal genetic testing market represents a continuum of early life risk identification that links reproductive planning, pregnancy management, and postnatal prevention into a single diagnostics value chain. The market combines policy anchored newborn screening programs with more commercially flexible prenatal testing, creating a hybrid structure where growth is driven both by guideline and reimbursement decisions and by consumer and clinician preference for earlier and more informative results. Competitive advantage increasingly depends on test performance, service reliability, counseling and clinical integration, and the ability to coordinate follow up pathways, because the economic value of testing is realized only when results trigger timely clinical action. Over time, market expansion is likely to be propelled by broader adoption of non invasive methods, richer test menus, and tighter integration with digital care workflows, while cost effectiveness scrutiny and ethical governance will shape the pace and direction of innovation.

This report studies the global Newborn and Prenatal Genetic Testing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Newborn and Prenatal Genetic Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Newborn and Prenatal Genetic Testing that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Newborn and Prenatal Genetic Testing total market, 2021-2032, (USD Million)
Global Newborn and Prenatal Genetic Testing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Newborn and Prenatal Genetic Testing total market, key domestic companies, and share, (USD Million)
Global Newborn and Prenatal Genetic Testing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Newborn and Prenatal Genetic Testing total market by Type, CAGR, 2021-2032, (USD Million)
Global Newborn and Prenatal Genetic Testing total market by Application, CAGR, 2021-2032, (USD Million)

This report profiles major players in the global Newborn and Prenatal Genetic Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB, Veritas Genetics, GGA, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Newborn and Prenatal Genetic Testing market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Newborn and Prenatal Genetic Testing Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Newborn and Prenatal Genetic Testing Market, Segmentation by Type:
  • NGS
  • Whole Exome Sequencing
  • Others
Global Newborn and Prenatal Genetic Testing Market, Segmentation by Screening Purpose:
  • Core Condition Screening
  • Expanded Condition Screening
Global Newborn and Prenatal Genetic Testing Market, Segmentation by Service Model:
  • Public Health Program
  • Consumer
  • Others
Global Newborn and Prenatal Genetic Testing Market, Segmentation by Application:
  • Public Hospitals
  • Private Hospitals
Companies Profiled:
  • Thermo Fisher Scientific
  • Revvity
  • Quest Diagnostics
  • MedGenome
  • Mayo Clinic Laboratories
  • GeneDx
  • PreventionGenetics
  • SYNLAB
  • Veritas Genetics
  • GGA
  • Cordlife
  • Rainbow Genomics
  • BGI Genomics
  • Berry Genomics
  • Annaroad
  • Jiajian Medical Testing
  • Genesky
  • Weihansi Biomedical Technology
Key Questions Answered
1. How big is the global Newborn and Prenatal Genetic Testing market?
2. What is the demand of the global Newborn and Prenatal Genetic Testing market?
3. What is the year over year growth of the global Newborn and Prenatal Genetic Testing market?
4. What is the total value of the global Newborn and Prenatal Genetic Testing market?
5. Who are the Major Players in the global Newborn and Prenatal Genetic Testing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Newborn and Prenatal Genetic Testing Introduction
1.2 World Newborn and Prenatal Genetic Testing Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Newborn and Prenatal Genetic Testing Total Market by Region (by Headquarter Location)
  1.3.1 World Newborn and Prenatal Genetic Testing Market Size by Region (2021-2032), (by Headquarter Location)
  1.3.2 United States Based Company Newborn and Prenatal Genetic Testing Revenue (2021-2032)
  1.3.3 China Based Company Newborn and Prenatal Genetic Testing Revenue (2021-2032)
  1.3.4 Europe Based Company Newborn and Prenatal Genetic Testing Revenue (2021-2032)
  1.3.5 Japan Based Company Newborn and Prenatal Genetic Testing Revenue (2021-2032)
  1.3.6 South Korea Based Company Newborn and Prenatal Genetic Testing Revenue (2021-2032)
  1.3.7 ASEAN Based Company Newborn and Prenatal Genetic Testing Revenue (2021-2032)
  1.3.8 India Based Company Newborn and Prenatal Genetic Testing Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Newborn and Prenatal Genetic Testing Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Major Market Trends

2 DEMAND SUMMARY

2.1 World Newborn and Prenatal Genetic Testing Consumption Value (2021-2032)
2.2 World Newborn and Prenatal Genetic Testing Consumption Value by Region
  2.2.1 World Newborn and Prenatal Genetic Testing Consumption Value by Region (2021-2026)
  2.2.2 World Newborn and Prenatal Genetic Testing Consumption Value Forecast by Region (2027-2032)
2.3 United States Newborn and Prenatal Genetic Testing Consumption Value (2021-2032)
2.4 China Newborn and Prenatal Genetic Testing Consumption Value (2021-2032)
2.5 Europe Newborn and Prenatal Genetic Testing Consumption Value (2021-2032)
2.6 Japan Newborn and Prenatal Genetic Testing Consumption Value (2021-2032)
2.7 South Korea Newborn and Prenatal Genetic Testing Consumption Value (2021-2032)
2.8 ASEAN Newborn and Prenatal Genetic Testing Consumption Value (2021-2032)
2.9 India Newborn and Prenatal Genetic Testing Consumption Value (2021-2032)

3 WORLD NEWBORN AND PRENATAL GENETIC TESTING COMPANIES COMPETITIVE ANALYSIS

3.1 World Newborn and Prenatal Genetic Testing Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Newborn and Prenatal Genetic Testing Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Newborn and Prenatal Genetic Testing in 2025
  3.2.3 Global Concentration Ratios (CR8) for Newborn and Prenatal Genetic Testing in 2025
3.3 Newborn and Prenatal Genetic Testing Company Evaluation Quadrant
3.4 Newborn and Prenatal Genetic Testing Market: Overall Company Footprint Analysis
  3.4.1 Newborn and Prenatal Genetic Testing Market: Region Footprint
  3.4.2 Newborn and Prenatal Genetic Testing Market: Company Product Type Footprint
  3.4.3 Newborn and Prenatal Genetic Testing Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Newborn and Prenatal Genetic Testing Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Newborn and Prenatal Genetic Testing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
  4.1.2 United States VS China: Newborn and Prenatal Genetic Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Newborn and Prenatal Genetic Testing Consumption Value Comparison
  4.2.1 United States VS China: Newborn and Prenatal Genetic Testing Consumption Value Comparison (2021 & 2025 & 2032)
  4.2.2 United States VS China: Newborn and Prenatal Genetic Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Newborn and Prenatal Genetic Testing Companies and Market Share, 2021-2026
  4.3.1 United States Based Newborn and Prenatal Genetic Testing Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Newborn and Prenatal Genetic Testing Revenue, (2021-2026)
4.4 China Based Companies Newborn and Prenatal Genetic Testing Revenue and Market Share, 2021-2026
  4.4.1 China Based Newborn and Prenatal Genetic Testing Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Newborn and Prenatal Genetic Testing Revenue, (2021-2026)
4.5 Rest of World Based Newborn and Prenatal Genetic Testing Companies and Market Share, 2021-2026
  4.5.1 Rest of World Based Newborn and Prenatal Genetic Testing Companies, Headquarters (Province, Country)
  4.5.2 Rest of World Based Companies Newborn and Prenatal Genetic Testing Revenue (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World Newborn and Prenatal Genetic Testing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
  5.2.1 NGS
  5.2.2 Whole Exome Sequencing
  5.2.3 Others
5.3 Market Segment by Type
  5.3.1 World Newborn and Prenatal Genetic Testing Market Size by Type (2021-2026)
  5.3.2 World Newborn and Prenatal Genetic Testing Market Size by Type (2027-2032)
  5.3.3 World Newborn and Prenatal Genetic Testing Market Size Market Share by Type (2027-2032)

6 MARKET ANALYSIS BY SCREENING PURPOSE

6.1 World Newborn and Prenatal Genetic Testing Market Size Overview by Screening Purpose: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Screening Purpose
  6.2.1 Core Condition Screening
  6.2.2 Expanded Condition Screening
6.3 Market Segment by Screening Purpose
  6.3.1 World Newborn and Prenatal Genetic Testing Market Size by Screening Purpose (2021-2026)
  6.3.2 World Newborn and Prenatal Genetic Testing Market Size by Screening Purpose (2027-2032)
  6.3.3 World Newborn and Prenatal Genetic Testing Market Size Market Share by Screening Purpose (2027-2032)

7 MARKET ANALYSIS BY SERVICE MODEL

7.1 World Newborn and Prenatal Genetic Testing Market Size Overview by Service Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Service Model
  7.2.1 Public Health Program
  7.2.2 Consumer
  7.2.3 Others
7.3 Market Segment by Service Model
  7.3.1 World Newborn and Prenatal Genetic Testing Market Size by Service Model (2021-2026)
  7.3.2 World Newborn and Prenatal Genetic Testing Market Size by Service Model (2027-2032)
  7.3.3 World Newborn and Prenatal Genetic Testing Market Size Market Share by Service Model (2027-2032)

8 MARKET ANALYSIS BY APPLICATION

8.1 World Newborn and Prenatal Genetic Testing Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
  8.2.1 Public Hospitals
  8.2.2 Private Hospitals
8.3 Market Segment by Application
  8.3.1 World Newborn and Prenatal Genetic Testing Market Size by Application (2021-2026)
  8.3.2 World Newborn and Prenatal Genetic Testing Market Size by Application (2027-2032)
  8.3.3 World Newborn and Prenatal Genetic Testing Market Size Market Share by Application (2021-2032)

9 COMPANY PROFILES

9.1 Thermo Fisher Scientific
  9.1.1 Thermo Fisher Scientific Details
  9.1.2 Thermo Fisher Scientific Major Business
  9.1.3 Thermo Fisher Scientific Newborn and Prenatal Genetic Testing Product and Services
  9.1.4 Thermo Fisher Scientific Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.1.5 Thermo Fisher Scientific Recent Developments/Updates
  9.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.2 Revvity
  9.2.1 Revvity Details
  9.2.2 Revvity Major Business
  9.2.3 Revvity Newborn and Prenatal Genetic Testing Product and Services
  9.2.4 Revvity Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.2.5 Revvity Recent Developments/Updates
  9.2.6 Revvity Competitive Strengths & Weaknesses
9.3 Quest Diagnostics
  9.3.1 Quest Diagnostics Details
  9.3.2 Quest Diagnostics Major Business
  9.3.3 Quest Diagnostics Newborn and Prenatal Genetic Testing Product and Services
  9.3.4 Quest Diagnostics Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.3.5 Quest Diagnostics Recent Developments/Updates
  9.3.6 Quest Diagnostics Competitive Strengths & Weaknesses
9.4 MedGenome
  9.4.1 MedGenome Details
  9.4.2 MedGenome Major Business
  9.4.3 MedGenome Newborn and Prenatal Genetic Testing Product and Services
  9.4.4 MedGenome Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.4.5 MedGenome Recent Developments/Updates
  9.4.6 MedGenome Competitive Strengths & Weaknesses
9.5 Mayo Clinic Laboratories
  9.5.1 Mayo Clinic Laboratories Details
  9.5.2 Mayo Clinic Laboratories Major Business
  9.5.3 Mayo Clinic Laboratories Newborn and Prenatal Genetic Testing Product and Services
  9.5.4 Mayo Clinic Laboratories Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.5.5 Mayo Clinic Laboratories Recent Developments/Updates
  9.5.6 Mayo Clinic Laboratories Competitive Strengths & Weaknesses
9.6 GeneDx
  9.6.1 GeneDx Details
  9.6.2 GeneDx Major Business
  9.6.3 GeneDx Newborn and Prenatal Genetic Testing Product and Services
  9.6.4 GeneDx Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.6.5 GeneDx Recent Developments/Updates
  9.6.6 GeneDx Competitive Strengths & Weaknesses
9.7 PreventionGenetics
  9.7.1 PreventionGenetics Details
  9.7.2 PreventionGenetics Major Business
  9.7.3 PreventionGenetics Newborn and Prenatal Genetic Testing Product and Services
  9.7.4 PreventionGenetics Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.7.5 PreventionGenetics Recent Developments/Updates
  9.7.6 PreventionGenetics Competitive Strengths & Weaknesses
9.8 SYNLAB
  9.8.1 SYNLAB Details
  9.8.2 SYNLAB Major Business
  9.8.3 SYNLAB Newborn and Prenatal Genetic Testing Product and Services
  9.8.4 SYNLAB Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.8.5 SYNLAB Recent Developments/Updates
  9.8.6 SYNLAB Competitive Strengths & Weaknesses
9.9 Veritas Genetics
  9.9.1 Veritas Genetics Details
  9.9.2 Veritas Genetics Major Business
  9.9.3 Veritas Genetics Newborn and Prenatal Genetic Testing Product and Services
  9.9.4 Veritas Genetics Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.9.5 Veritas Genetics Recent Developments/Updates
  9.9.6 Veritas Genetics Competitive Strengths & Weaknesses
9.10 GGA
  9.10.1 GGA Details
  9.10.2 GGA Major Business
  9.10.3 GGA Newborn and Prenatal Genetic Testing Product and Services
  9.10.4 GGA Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.10.5 GGA Recent Developments/Updates
  9.10.6 GGA Competitive Strengths & Weaknesses
9.11 Cordlife
  9.11.1 Cordlife Details
  9.11.2 Cordlife Major Business
  9.11.3 Cordlife Newborn and Prenatal Genetic Testing Product and Services
  9.11.4 Cordlife Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.11.5 Cordlife Recent Developments/Updates
  9.11.6 Cordlife Competitive Strengths & Weaknesses
9.12 Rainbow Genomics
  9.12.1 Rainbow Genomics Details
  9.12.2 Rainbow Genomics Major Business
  9.12.3 Rainbow Genomics Newborn and Prenatal Genetic Testing Product and Services
  9.12.4 Rainbow Genomics Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.12.5 Rainbow Genomics Recent Developments/Updates
  9.12.6 Rainbow Genomics Competitive Strengths & Weaknesses
9.13 BGI Genomics
  9.13.1 BGI Genomics Details
  9.13.2 BGI Genomics Major Business
  9.13.3 BGI Genomics Newborn and Prenatal Genetic Testing Product and Services
  9.13.4 BGI Genomics Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.13.5 BGI Genomics Recent Developments/Updates
  9.13.6 BGI Genomics Competitive Strengths & Weaknesses
9.14 Berry Genomics
  9.14.1 Berry Genomics Details
  9.14.2 Berry Genomics Major Business
  9.14.3 Berry Genomics Newborn and Prenatal Genetic Testing Product and Services
  9.14.4 Berry Genomics Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.14.5 Berry Genomics Recent Developments/Updates
  9.14.6 Berry Genomics Competitive Strengths & Weaknesses
9.15 Annaroad
  9.15.1 Annaroad Details
  9.15.2 Annaroad Major Business
  9.15.3 Annaroad Newborn and Prenatal Genetic Testing Product and Services
  9.15.4 Annaroad Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.15.5 Annaroad Recent Developments/Updates
  9.15.6 Annaroad Competitive Strengths & Weaknesses
9.16 Jiajian Medical Testing
  9.16.1 Jiajian Medical Testing Details
  9.16.2 Jiajian Medical Testing Major Business
  9.16.3 Jiajian Medical Testing Newborn and Prenatal Genetic Testing Product and Services
  9.16.4 Jiajian Medical Testing Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.16.5 Jiajian Medical Testing Recent Developments/Updates
  9.16.6 Jiajian Medical Testing Competitive Strengths & Weaknesses
9.17 Genesky
  9.17.1 Genesky Details
  9.17.2 Genesky Major Business
  9.17.3 Genesky Newborn and Prenatal Genetic Testing Product and Services
  9.17.4 Genesky Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.17.5 Genesky Recent Developments/Updates
  9.17.6 Genesky Competitive Strengths & Weaknesses
9.18 Weihansi Biomedical Technology
  9.18.1 Weihansi Biomedical Technology Details
  9.18.2 Weihansi Biomedical Technology Major Business
  9.18.3 Weihansi Biomedical Technology Newborn and Prenatal Genetic Testing Product and Services
  9.18.4 Weihansi Biomedical Technology Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.18.5 Weihansi Biomedical Technology Recent Developments/Updates
  9.18.6 Weihansi Biomedical Technology Competitive Strengths & Weaknesses

10 INDUSTRY CHAIN ANALYSIS

10.1 Newborn and Prenatal Genetic Testing Industry Chain
10.2 Newborn and Prenatal Genetic Testing Upstream Analysis
10.3 Newborn and Prenatal Genetic Testing Midstream Analysis
10.4 Newborn and Prenatal Genetic Testing Downstream Analysis

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer


LIST OF TABLES

Table 1. World Newborn and Prenatal Genetic Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Newborn and Prenatal Genetic Testing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Newborn and Prenatal Genetic Testing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Newborn and Prenatal Genetic Testing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Newborn and Prenatal Genetic Testing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Newborn and Prenatal Genetic Testing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Newborn and Prenatal Genetic Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Newborn and Prenatal Genetic Testing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Newborn and Prenatal Genetic Testing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Newborn and Prenatal Genetic Testing Players in 2025
Table 12. World Newborn and Prenatal Genetic Testing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Newborn and Prenatal Genetic Testing Company Evaluation Quadrant
Table 14. Head Office of Key Newborn and Prenatal Genetic Testing Players
Table 15. Newborn and Prenatal Genetic Testing Market: Company Product Type Footprint
Table 16. Newborn and Prenatal Genetic Testing Market: Company Product Application Footprint
Table 17. Newborn and Prenatal Genetic Testing Mergers & Acquisitions Activity
Table 18. United States VS China Newborn and Prenatal Genetic Testing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Newborn and Prenatal Genetic Testing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Newborn and Prenatal Genetic Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Newborn and Prenatal Genetic Testing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Newborn and Prenatal Genetic Testing Revenue Market Share (2021-2026)
Table 23. China Based Newborn and Prenatal Genetic Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Newborn and Prenatal Genetic Testing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Newborn and Prenatal Genetic Testing Revenue Market Share (2021-2026)
Table 26. Rest of World Based Newborn and Prenatal Genetic Testing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Newborn and Prenatal Genetic Testing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Newborn and Prenatal Genetic Testing Revenue Market Share (2021-2026)
Table 29. World Newborn and Prenatal Genetic Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Newborn and Prenatal Genetic Testing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Newborn and Prenatal Genetic Testing Market Size by Type (2027-2032) & (USD Million)
Table 32. World Newborn and Prenatal Genetic Testing Market Size by Screening Purpose, (USD Million), 2021 & 2025 & 2032
Table 33. World Newborn and Prenatal Genetic Testing Market Size Value by Screening Purpose (2021-2026) & (USD Million)
Table 34. World Newborn and Prenatal Genetic Testing Market Size by Screening Purpose (2027-2032) & (USD Million)
Table 35. World Newborn and Prenatal Genetic Testing Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Table 36. World Newborn and Prenatal Genetic Testing Market Size Value by Service Model (2021-2026) & (USD Million)
Table 37. World Newborn and Prenatal Genetic Testing Market Size by Service Model (2027-2032) & (USD Million)
Table 38. World Newborn and Prenatal Genetic Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Newborn and Prenatal Genetic Testing Market Size by Application (2021-2026) & (USD Million)
Table 40. World Newborn and Prenatal Genetic Testing Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific Newborn and Prenatal Genetic Testing Product and Services
Table 44. Thermo Fisher Scientific Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Revvity Basic Information, Manufacturing Base and Competitors
Table 48. Revvity Major Business
Table 49. Revvity Newborn and Prenatal Genetic Testing Product and Services
Table 50. Revvity Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Revvity Recent Developments/Updates
Table 52. Revvity Competitive Strengths & Weaknesses
Table 53. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 54. Quest Diagnostics Major Business
Table 55. Quest Diagnostics Newborn and Prenatal Genetic Testing Product and Services
Table 56. Quest Diagnostics Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Quest Diagnostics Recent Developments/Updates
Table 58. Quest Diagnostics Competitive Strengths & Weaknesses
Table 59. MedGenome Basic Information, Manufacturing Base and Competitors
Table 60. MedGenome Major Business
Table 61. MedGenome Newborn and Prenatal Genetic Testing Product and Services
Table 62. MedGenome Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. MedGenome Recent Developments/Updates
Table 64. MedGenome Competitive Strengths & Weaknesses
Table 65. Mayo Clinic Laboratories Basic Information, Manufacturing Base and Competitors
Table 66. Mayo Clinic Laboratories Major Business
Table 67. Mayo Clinic Laboratories Newborn and Prenatal Genetic Testing Product and Services
Table 68. Mayo Clinic Laboratories Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Mayo Clinic Laboratories Recent Developments/Updates
Table 70. Mayo Clinic Laboratories Competitive Strengths & Weaknesses
Table 71. GeneDx Basic Information, Manufacturing Base and Competitors
Table 72. GeneDx Major Business
Table 73. GeneDx Newborn and Prenatal Genetic Testing Product and Services
Table 74. GeneDx Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. GeneDx Recent Developments/Updates
Table 76. GeneDx Competitive Strengths & Weaknesses
Table 77. PreventionGenetics Basic Information, Manufacturing Base and Competitors
Table 78. PreventionGenetics Major Business
Table 79. PreventionGenetics Newborn and Prenatal Genetic Testing Product and Services
Table 80. PreventionGenetics Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. PreventionGenetics Recent Developments/Updates
Table 82. PreventionGenetics Competitive Strengths & Weaknesses
Table 83. SYNLAB Basic Information, Manufacturing Base and Competitors
Table 84. SYNLAB Major Business
Table 85. SYNLAB Newborn and Prenatal Genetic Testing Product and Services
Table 86. SYNLAB Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. SYNLAB Recent Developments/Updates
Table 88. SYNLAB Competitive Strengths & Weaknesses
Table 89. Veritas Genetics Basic Information, Manufacturing Base and Competitors
Table 90. Veritas Genetics Major Business
Table 91. Veritas Genetics Newborn and Prenatal Genetic Testing Product and Services
Table 92. Veritas Genetics Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Veritas Genetics Recent Developments/Updates
Table 94. Veritas Genetics Competitive Strengths & Weaknesses
Table 95. GGA Basic Information, Manufacturing Base and Competitors
Table 96. GGA Major Business
Table 97. GGA Newborn and Prenatal Genetic Testing Product and Services
Table 98. GGA Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. GGA Recent Developments/Updates
Table 100. GGA Competitive Strengths & Weaknesses
Table 101. Cordlife Basic Information, Manufacturing Base and Competitors
Table 102. Cordlife Major Business
Table 103. Cordlife Newborn and Prenatal Genetic Testing Product and Services
Table 104. Cordlife Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Cordlife Recent Developments/Updates
Table 106. Cordlife Competitive Strengths & Weaknesses
Table 107. Rainbow Genomics Basic Information, Manufacturing Base and Competitors
Table 108. Rainbow Genomics Major Business
Table 109. Rainbow Genomics Newborn and Prenatal Genetic Testing Product and Services
Table 110. Rainbow Genomics Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Rainbow Genomics Recent Developments/Updates
Table 112. Rainbow Genomics Competitive Strengths & Weaknesses
Table 113. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 114. BGI Genomics Major Business
Table 115. BGI Genomics Newborn and Prenatal Genetic Testing Product and Services
Table 116. BGI Genomics Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. BGI Genomics Recent Developments/Updates
Table 118. BGI Genomics Competitive Strengths & Weaknesses
Table 119. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 120. Berry Genomics Major Business
Table 121. Berry Genomics Newborn and Prenatal Genetic Testing Product and Services
Table 122. Berry Genomics Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Berry Genomics Recent Developments/Updates
Table 124. Berry Genomics Competitive Strengths & Weaknesses
Table 125. Annaroad Basic Information, Manufacturing Base and Competitors
Table 126. Annaroad Major Business
Table 127. Annaroad Newborn and Prenatal Genetic Testing Product and Services
Table 128. Annaroad Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Annaroad Recent Developments/Updates
Table 130. Annaroad Competitive Strengths & Weaknesses
Table 131. Jiajian Medical Testing Basic Information, Manufacturing Base and Competitors
Table 132. Jiajian Medical Testing Major Business
Table 133. Jiajian Medical Testing Newborn and Prenatal Genetic Testing Product and Services
Table 134. Jiajian Medical Testing Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Jiajian Medical Testing Recent Developments/Updates
Table 136. Jiajian Medical Testing Competitive Strengths & Weaknesses
Table 137. Genesky Basic Information, Manufacturing Base and Competitors
Table 138. Genesky Major Business
Table 139. Genesky Newborn and Prenatal Genetic Testing Product and Services
Table 140. Genesky Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Genesky Recent Developments/Updates
Table 142. Genesky Competitive Strengths & Weaknesses
Table 143. Weihansi Biomedical Technology Basic Information, Manufacturing Base and Competitors
Table 144. Weihansi Biomedical Technology Major Business
Table 145. Weihansi Biomedical Technology Newborn and Prenatal Genetic Testing Product and Services
Table 146. Weihansi Biomedical Technology Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Weihansi Biomedical Technology Recent Developments/Updates
Table 148. Weihansi Biomedical Technology Competitive Strengths & Weaknesses
Table 149. Global Key Players of Newborn and Prenatal Genetic Testing Upstream (Raw Materials)
Table 150. Global Newborn and Prenatal Genetic Testing Typical Customers

LIST OF FIGURES

Figure 1. Newborn and Prenatal Genetic Testing Picture
Figure 2. World Newborn and Prenatal Genetic Testing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Newborn and Prenatal Genetic Testing Total Revenue (2021-2032) & (USD Million)
Figure 4. World Newborn and Prenatal Genetic Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Newborn and Prenatal Genetic Testing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Newborn and Prenatal Genetic Testing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Newborn and Prenatal Genetic Testing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Newborn and Prenatal Genetic Testing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Newborn and Prenatal Genetic Testing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Newborn and Prenatal Genetic Testing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Newborn and Prenatal Genetic Testing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Newborn and Prenatal Genetic Testing Revenue (2021-2032) & (USD Million)
Figure 13. Newborn and Prenatal Genetic Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Newborn and Prenatal Genetic Testing Consumption Value (2021-2032) & (USD Million)
Figure 16. World Newborn and Prenatal Genetic Testing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Newborn and Prenatal Genetic Testing Consumption Value (2021-2032) & (USD Million)
Figure 18. China Newborn and Prenatal Genetic Testing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Newborn and Prenatal Genetic Testing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Newborn and Prenatal Genetic Testing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Newborn and Prenatal Genetic Testing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Newborn and Prenatal Genetic Testing Consumption Value (2021-2032) & (USD Million)
Figure 23. India Newborn and Prenatal Genetic Testing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Newborn and Prenatal Genetic Testing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Newborn and Prenatal Genetic Testing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Newborn and Prenatal Genetic Testing Markets in 2025
Figure 27. United States VS China: Newborn and Prenatal Genetic Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Newborn and Prenatal Genetic Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Newborn and Prenatal Genetic Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Newborn and Prenatal Genetic Testing Market Size Market Share by Type in 2025
Figure 31. NGS
Figure 32. Whole Exome Sequencing
Figure 33. Others
Figure 34. World Newborn and Prenatal Genetic Testing Market Size Market Share by Type (2021-2032)
Figure 35. World Newborn and Prenatal Genetic Testing Market Size by Screening Purpose, (USD Million), 2021 & 2025 & 2032
Figure 36. World Newborn and Prenatal Genetic Testing Market Size Market Share by Screening Purpose in 2025
Figure 37. Core Condition Screening
Figure 38. Expanded Condition Screening
Figure 39. World Newborn and Prenatal Genetic Testing Market Size Market Share by Screening Purpose (2021-2032)
Figure 40. World Newborn and Prenatal Genetic Testing Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 41. World Newborn and Prenatal Genetic Testing Market Size Market Share by Service Model in 2025
Figure 42. Public Health Program
Figure 43. Consumer
Figure 44. Others
Figure 45. World Newborn and Prenatal Genetic Testing Market Size Market Share by Service Model (2021-2032)
Figure 46. World Newborn and Prenatal Genetic Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Newborn and Prenatal Genetic Testing Market Size Market Share by Application in 2025
Figure 48. Public Hospitals
Figure 49. Private Hospitals
Figure 50. World Newborn and Prenatal Genetic Testing Market Size Market Share by Application (2021-2032)
Figure 51. Newborn and Prenatal Genetic Testing Industrial Chain
Figure 52. Methodology
Figure 53. Research Process and Data Source


More Publications